Background. Nonalcoholic fatty liver disease (NAFLD) is closely related to the metabolism disorders of fatty acids. The pathogenesis of the disease includes an increased concentration of FFA in blood, an increase in the biosynthesis of fatty acids, and disorders in the process of β-oxidation. Objective. The aim of the study was to analyze the fatty acids in erythrocyte membranes among 55 patients with NAFLD who were subjected to a 6-month dietary intervention in order to reduce fatty liver. Materials and Methods. Basic anthropometric and biochemical measurements were performed. The profile of fatty acids was measured in the membranes of erythrocytes and analyzed by gas chromatography. The dietary compliance was evaluated using 72-diary ques...
Objectives. Nonalcoholic fatty liver disease (NAFLD) and hyperlipidemia (HL) are common metabolic di...
© 2017 Dr Kang-Yu PengNon-alcoholic fatty liver disease (NAFLD) has become a major threat to the liv...
Background/Objectives Treatment of subjects with non-alcoholic fatty liver disease (NAFLD) with omeg...
Objective: Our aim was to study the fatty acid (FA) composition of liver phospholipids and its relat...
Changes in lipid metabolism occur during the development and progression non-alcoholic fatty liver d...
Background: Free fatty acid (FFA) metabolism can impact on metabolic conditions, such as obesity and...
Background: Non-alcoholic fatty liver disease (NAFLD) is a wide spectrum condition characterized by ...
Introduction and objectives: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation o...
NAFLD is characterised by fatty infiltration of the liver, mostly in the form of triglycerides, whic...
Our aim was to study the influence of weight loss on the fatty acid (FA) composition of liver and er...
ABSTRACT. Background: End stage liver disease (ESLD) is a devastating illness. Its protean manifesta...
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease globally. The first st...
Non-alcoholic fatty liver disease (NAFLD) is a major public health problem worldwide. NAFLD (both si...
Non-alcoholic fatty liver disease (NAFLD) ranges from steatosis and hepatic insulin resistance to no...
Background. Non-alcoholic fatty liver disease (NAFLD) is a chronic diffuse liver pathology that incl...
Objectives. Nonalcoholic fatty liver disease (NAFLD) and hyperlipidemia (HL) are common metabolic di...
© 2017 Dr Kang-Yu PengNon-alcoholic fatty liver disease (NAFLD) has become a major threat to the liv...
Background/Objectives Treatment of subjects with non-alcoholic fatty liver disease (NAFLD) with omeg...
Objective: Our aim was to study the fatty acid (FA) composition of liver phospholipids and its relat...
Changes in lipid metabolism occur during the development and progression non-alcoholic fatty liver d...
Background: Free fatty acid (FFA) metabolism can impact on metabolic conditions, such as obesity and...
Background: Non-alcoholic fatty liver disease (NAFLD) is a wide spectrum condition characterized by ...
Introduction and objectives: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation o...
NAFLD is characterised by fatty infiltration of the liver, mostly in the form of triglycerides, whic...
Our aim was to study the influence of weight loss on the fatty acid (FA) composition of liver and er...
ABSTRACT. Background: End stage liver disease (ESLD) is a devastating illness. Its protean manifesta...
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease globally. The first st...
Non-alcoholic fatty liver disease (NAFLD) is a major public health problem worldwide. NAFLD (both si...
Non-alcoholic fatty liver disease (NAFLD) ranges from steatosis and hepatic insulin resistance to no...
Background. Non-alcoholic fatty liver disease (NAFLD) is a chronic diffuse liver pathology that incl...
Objectives. Nonalcoholic fatty liver disease (NAFLD) and hyperlipidemia (HL) are common metabolic di...
© 2017 Dr Kang-Yu PengNon-alcoholic fatty liver disease (NAFLD) has become a major threat to the liv...
Background/Objectives Treatment of subjects with non-alcoholic fatty liver disease (NAFLD) with omeg...